SIRT1 and metabolic dysfunction-associated steatohepatitis: In in vitro experiments, we revealed that the coincubation with autophagy flux blocker (BAF) abolished elafibranor-related SIRT1-mediated inhibition of NASH-sera-induced pathogenic signals in podocytes and HK-2 cells.